{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T01:48:14Z","timestamp":1782352094207,"version":"3.54.5"},"reference-count":50,"publisher":"Maximum Academic Press","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["PEDI"],"published-print":{"date-parts":[[2026]]},"DOI":"10.48130\/pedi-0026-0003","type":"journal-article","created":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T00:49:57Z","timestamp":1782262197000},"page":"0-0","source":"Crossref","is-referenced-by-count":0,"title":["Early life antibiotic-use and risk of childhood type 1 diabetes: a nationwide cohort study utilising data linkage"],"prefix":"10.48130","volume":"2026","author":[{"given":"Sharan","family":"Ram","sequence":"first","affiliation":[{}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marine","family":"Corbin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Eng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Kvalsvig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael G.","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"'t Mannetje","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeroen","family":"Douwes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"27968","reference":[{"key":"key-10.48130\/pedi-0026-0003-1","doi-asserted-by":"publisher","unstructured":"

Gomber A, Ward ZJ, Ross C, Owais M, Mita C, et al. 2022. Variation in the incidence of type 1 diabetes mellitus in children and adolescents by world region and country income group: a scoping review. PLoS Global Public Health<\/ext-link><\/i> 2(11):e0001099<\/p>","DOI":"10.1371\/journal.pgph.0001099"},{"key":"key-10.48130\/pedi-0026-0003-2","doi-asserted-by":"publisher","unstructured":"

Gong B, Yang W, Xing Y, Lai Y, Shan Z. 2025. Global, regional, and national burden of type 1 diabetes in adolescents and young adults. Pediatric Research<\/ext-link><\/i> 97(2):568\u2212576<\/p>","DOI":"10.1038\/s41390-024-03107-5"},{"key":"key-10.48130\/pedi-0026-0003-3","doi-asserted-by":"publisher","unstructured":"

Gregory GA, Robinson TIG, Linklater SE, Wang F, Colagiuri S, et al. 2022. Global incidence, prevalence, and mortality of type 1 diabetes in 2021 with projection to 2040: a modelling study. The Lancet Diabetes & Endocrinology<\/ext-link><\/i> 10(10):741\u2212760<\/p>","DOI":"10.1016\/S2213-8587(22)00218-2"},{"key":"key-10.48130\/pedi-0026-0003-4","doi-asserted-by":"publisher","unstructured":"

Ward ZJ, Yeh JM, Reddy CL, Gomber A, Ross C, et al. 2022. Estimating the total incidence of type 1 diabetes in children and adolescents aged 0\u201319 years from 1990 to 2050: a global simulation-based analysis. The Lancet Diabetes & Endocrinology<\/ext-link><\/i> 10(12):848\u2212858<\/p>","DOI":"10.1016\/S2213-8587(22)00276-5"},{"key":"key-10.48130\/pedi-0026-0003-5","doi-asserted-by":"publisher","unstructured":"

Bauer W, Gyenesei A, Kr\u0119towski A. 2021. The multifactorial progression from the islet autoimmunity to type 1 diabetes in children. International Journal of Molecular Sciences<\/ext-link><\/i> 22(14):7493<\/p>","DOI":"10.3390\/ijms22147493"},{"key":"key-10.48130\/pedi-0026-0003-6","doi-asserted-by":"publisher","unstructured":"

Abdellatif AM, Sarvetnick NE. 2019. Current understanding of the role of gut dysbiosis in type 1 diabetes. Journal of Diabetes<\/ext-link><\/i> 11(8):632\u2212644<\/p>","DOI":"10.1111\/1753-0407.12915"},{"key":"key-10.48130\/pedi-0026-0003-7","doi-asserted-by":"publisher","unstructured":"

Zhou H, Sun L, Zhang S, Zhao X, Gang X, et al. 2020. Evaluating the causal role of gut microbiota in type 1 diabetes and its possible pathogenic mechanisms. Frontiers in Endocrinology<\/ext-link><\/i> 11:125<\/p>","DOI":"10.3389\/fendo.2020.00125"},{"key":"key-10.48130\/pedi-0026-0003-8","doi-asserted-by":"publisher","unstructured":"

de Goffau MC, Luopaj\u00e4rvi K, Knip M, Ilonen J, Ruohtula T, et al. 2013. Fecal microbiota composition differs between children with \u03b2-cell autoimmunity and those without. Diabetes<\/ext-link><\/i> 62(4):1238\u22121244<\/p>","DOI":"10.2337\/db12-0526"},{"key":"key-10.48130\/pedi-0026-0003-9","doi-asserted-by":"publisher","unstructured":"

Jamshidi P, Hasanzadeh S, Tahvildari A, Farsi Y, Arbabi M, et al. 2019. Is there any association between gut microbiota and type 1 diabetes? A systematic review. Gut Pathogens<\/ext-link><\/i> 11(1):49<\/p>","DOI":"10.1186\/s13099-019-0332-7"},{"key":"key-10.48130\/pedi-0026-0003-10","doi-asserted-by":"publisher","unstructured":"

Davis-Richardson AG, Triplett EW. 2015. A model for the role of gut bacteria in the development of autoimmunity for type 1 diabetes. Diabetologia<\/ext-link><\/i> 58(7):1386\u22121393<\/p>","DOI":"10.1007\/s00125-015-3614-8"},{"key":"key-10.48130\/pedi-0026-0003-11","doi-asserted-by":"publisher","unstructured":"

Tapia G, St\u00f8rdal K, M\u00e5rild K, Kahrs CR, Skrivarhaug T, et al. 2018. Antibiotics, acetaminophen and infections during prenatal and early life in relation to type 1 diabetes. International Journal of Epidemiology<\/ext-link><\/i> 47(5):1538\u22121548<\/p>","DOI":"10.1093\/ije\/dyy092"},{"key":"key-10.48130\/pedi-0026-0003-12","doi-asserted-by":"publisher","unstructured":"

Haupt-J\u00f8rgensen M, Morgen CS, Jess T, Buschard K, Josefsen K, et al. 2018. Maternal antibiotic use during pregnancy and type 1 diabetes in children\u2014a national prospective cohort study. Diabetes Care<\/ext-link><\/i> 41(12):e155\u2212e157<\/p>","DOI":"10.2337\/dc18-1764"},{"key":"key-10.48130\/pedi-0026-0003-13","doi-asserted-by":"publisher","unstructured":"

Kilkkinen A, Virtanen SM, Klaukka T, Kenward MG, Salkinoja-Salonen M, et al. 2006. Use of antimicrobials and risk of type 1 diabetes in a population-based mother\u2013child cohort. Diabetologia<\/ext-link><\/i> 49(1):66\u221270<\/p>","DOI":"10.1007\/s00125-005-0078-2"},{"key":"key-10.48130\/pedi-0026-0003-14","doi-asserted-by":"publisher","unstructured":"

Hakola L, Lundqvist A, Gissler M, Virta LJ, Virtanen SM, et al. 2025. Prenatal and postnatal exposure to antibiotics and the risk of type 1 diabetes in Finnish children: a registry-based study. The Journal of Pediatrics<\/ext-link><\/i> 276:114292<\/p>","DOI":"10.1016\/j.jpeds.2024.114292"},{"key":"key-10.48130\/pedi-0026-0003-15","doi-asserted-by":"publisher","unstructured":"

Clausen TD, Bergholt T, Bouaziz O, Arpi M, Eriksson F, et al. 2016. Broad-spectrum antibiotic treatment and subsequent childhood type 1 diabetes: a nationwide Danish cohort study. PLoS One<\/ext-link><\/i> 11(8):e0161654<\/p>","DOI":"10.1371\/journal.pone.0161654"},{"key":"key-10.48130\/pedi-0026-0003-16","doi-asserted-by":"publisher","unstructured":"

Wernroth ML, Fall K, Svennblad B, Ludvigsson JF, Sj\u00f6lander A, et al. 2020. Early childhood antibiotic treatment for otitis media and other respiratory tract infections is associated with risk of type 1 diabetes: a nationwide register-based study with sibling analysis. Diabetes Care<\/ext-link><\/i> 43(5):991\u2212999<\/p>","DOI":"10.2337\/dc19-1162"},{"key":"key-10.48130\/pedi-0026-0003-17","doi-asserted-by":"publisher","unstructured":"

Antvorskov JC, Morgen CS, Buschard K, Jess T, Allin KH, et al. 2020. Antibiotic treatment during early childhood and risk of type 1 diabetes in children: a national birth cohort study. Pediatric Diabetes<\/ext-link><\/i> 21(8):1457\u22121464<\/p>","DOI":"10.1111\/pedi.13111"},{"key":"key-10.48130\/pedi-0026-0003-18","doi-asserted-by":"publisher","unstructured":"

Cardwell CR, Carson DJ, Patterson CC. 2008. No association between routinely recorded infections in early life and subsequent risk of childhood-onset Type 1 diabetes: a matched case\u2013control study using the UK General Practice Research Database. Diabetic Medicine<\/ext-link><\/i> 25(3):261\u2212267<\/p>","DOI":"10.1111\/j.1464-5491.2007.02351.x"},{"key":"key-10.48130\/pedi-0026-0003-19","doi-asserted-by":"publisher","unstructured":"

Lee D, Choi S, Chang J, Park YJ, Kim JH, et al. 2022. Association of antibiotics exposure within the first 2 years after birth with subsequent childhood type 1 diabetes. Endocrine<\/ext-link><\/i> 77(1):21\u221229<\/p>","DOI":"10.1007\/s12020-022-03042-7"},{"key":"key-10.48130\/pedi-0026-0003-20","doi-asserted-by":"publisher","unstructured":"

Kemppainen KM, Vehik K, Lynch KF, Larsson HE, Canepa RJ, et al. 2017. Association between early-life antibiotic use and the risk of islet or celiac disease autoimmunity. JAMA Pediatrics<\/ext-link><\/i> 171(12):1217<\/p>","DOI":"10.1001\/jamapediatrics.2017.2905"},{"key":"key-10.48130\/pedi-0026-0003-21","doi-asserted-by":"publisher","unstructured":"

Zhou H, Sun L, Zhang S, Zhao X, Gang X, et al. 2021. The crucial role of early-life gut microbiota in the development of type 1 diabetes. Acta Diabetologica<\/ext-link><\/i> 58(3):249\u2212265<\/p>","DOI":"10.1007\/s00592-020-01563-z"},{"key":"key-10.48130\/pedi-0026-0003-22","doi-asserted-by":"publisher","unstructured":"

Fenneman AC, Rampanelli E, Yin YS, Ames J, Blaser MJ, et al. 2020. Gut microbiota and metabolites in the pathogenesis of endocrine disease. Biochemical Society Transactions<\/ext-link><\/i> 48(3):915\u2212931<\/p>","DOI":"10.1042\/bst20190686"},{"key":"key-10.48130\/pedi-0026-0003-23","doi-asserted-by":"publisher","unstructured":"

Fenneman AC, Weidner M, Chen LA, Nieuwdorp M, Blaser MJ. 2023. Antibiotics in the pathogenesis of diabetes and inflammatory diseases of the gastrointestinal tract. Nature Reviews Gastroenterology & Hepatology<\/ext-link><\/i> 20(2):81\u2212100<\/p>","DOI":"10.1038\/s41575-022-00685-9"},{"key":"key-10.48130\/pedi-0026-0003-24","doi-asserted-by":"publisher","unstructured":"

Hu Y, Wong FS, Wen L. 2017. Antibiotics, gut microbiota, environment in early life and type 1 diabetes. Pharmacological Research<\/ext-link><\/i> 119:219\u2212226<\/p>","DOI":"10.1016\/j.phrs.2017.01.034"},{"key":"key-10.48130\/pedi-0026-0003-25","doi-asserted-by":"publisher","unstructured":"

Huang H, Jiang J, Wang X, Jiang K, Cao H. 2024. Exposure to prescribed medication in early life and impacts on gut microbiota and disease development. eClinicalMedicine<\/ext-link><\/i> 68:102428<\/p>","DOI":"10.1016\/j.eclinm.2024.102428"},{"key":"key-10.48130\/pedi-0026-0003-26","doi-asserted-by":"publisher","unstructured":"

Ramirez J, Guarner F, Bustos Fernandez L, Maruy A, Sdepanian VL, et al. 2020. Antibiotics as major disruptors of gut microbiota. Frontiers in Cellular and Infection Microbiology<\/ext-link><\/i> 10:572912<\/p>","DOI":"10.3389\/fcimb.2020.572912"},{"key":"key-10.48130\/pedi-0026-0003-27","doi-asserted-by":"publisher","unstructured":"

Williamson DA, Roos R, Verrall A, Smith A, Thomas MG. 2016. Trends, demographics and disparities in outpatient antibiotic consumption in New Zealand: a national study. Journal of Antimicrobial Chemotherapy<\/ext-link><\/i> 71(12):3593\u22123598<\/p>","DOI":"10.1093\/jac\/dkw345"},{"key":"key-10.48130\/pedi-0026-0003-28","doi-asserted-by":"publisher","unstructured":"

Zhang C, Li L, Jin B, Xu X, Zuo X, et al. 2021. The effects of delivery mode on the gut microbiota and health: state of art. Frontiers in Microbiology<\/ext-link><\/i> 12:724449<\/p>","DOI":"10.3389\/fmicb.2021.724449"},{"key":"key-10.48130\/pedi-0026-0003-29","doi-asserted-by":"publisher","unstructured":"

Korpela K. 2021. Impact of delivery mode on infant gut microbiota. Annals of Nutrition and Metabolism<\/ext-link><\/i> 77:11\u221219<\/p>","DOI":"10.1159\/000518498"},{"key":"key-10.48130\/pedi-0026-0003-30","doi-asserted-by":"publisher","unstructured":"

Milne BJ, Atkinson J, Blakely T, Day H, Douwes J, et al. 2019. Data resource profile: the New Zealand integrated data infrastructure (IDI). International Journal of Epidemiology<\/ext-link><\/i> 48(3):677\u2212677e<\/p>","DOI":"10.1093\/ije\/dyz014"},{"key":"key-10.48130\/pedi-0026-0003-31","doi-asserted-by":"publisher","unstructured":"

Milne BJ. 2022. Longitudinal research in Aotearoa<\/i> New Zealand using the Integrated Data Infrastructure: a review. Journal of the Royal Society of New Zealand<\/ext-link><\/i> 52(3):301\u2212312<\/p>","DOI":"10.1080\/03036758.2022.2072905"},{"key":"key-10.48130\/pedi-0026-0003-32","doi-asserted-by":"publisher","unstructured":"

Ram S, Corbin M, 't Mannetje A, Eng A, Kvalsvig A, et al. 2025. Antibiotic use in utero<\/i> and early life and risk of chronic childhood conditions in New Zealand: protocol for a data linkage retrospective cohort study. JMIR Research Protocols<\/ext-link><\/i> 14:e66184<\/p>","DOI":"10.2196\/66184"},{"key":"key-10.48130\/pedi-0026-0003-33","doi-asserted-by":"publisher","unstructured":"

Nogacka AM, Salazar N, Arboleya S, Su\u00e1rez M, Fern\u00e1ndez N, et al. 2018. Early microbiota, antibiotics and health. Cellular and Molecular Life Sciences<\/ext-link><\/i> 75(1):83\u221291<\/p>","DOI":"10.1007\/s00018-017-2670-2"},{"key":"key-10.48130\/pedi-0026-0003-34","unstructured":"

Drugs. com. n.d. www.drugs.com\/drug_information.html<\/ext-link><\/p>"},{"key":"key-10.48130\/pedi-0026-0003-35","doi-asserted-by":"publisher","unstructured":"

McKergow E, Parkin L, Barson DJ, Sharples KJ, Wheeler BJ. 2017. Demographic and regional disparities in insulin pump utilization in a setting of universal funding: a New Zealand nationwide study. Acta Diabetologica<\/ext-link><\/i> 54(1):63\u221271<\/p>","DOI":"10.1007\/s00592-016-0912-7"},{"key":"key-10.48130\/pedi-0026-0003-36","unstructured":"

Ministry of Health. 2016. Health Loss in New Zealand 1990\u20132013: A report from the New Zealand Burden of Diseases, Injuries and Risk Factors Study. Report<\/i>. Wellington, New Zealand: Ministry of Health Wellington. www.health.govt.nz\/publications\/health-loss-in-new-zealand-1990-2013<\/ext-link><\/p>"},{"key":"key-10.48130\/pedi-0026-0003-37","unstructured":"

Ministry of Health. 2004. Ethnicity data protocols for the health and disability sector. Wellington, New Zealand: Ministry of Health Wellington. www.fmhs.auckland.ac.nz\/assets\/fmhs\/faculty\/tkhm\/tumuaki\/docs\/ethnicity-data-protocols.pdf<\/ext-link><\/p>"},{"key":"key-10.48130\/pedi-0026-0003-38","unstructured":"

Atkinson J, Salmond C, Crampton P. 2019. NZDep2018 Index of Deprivation, interim research report. Interim Research Report<\/i>. Wellington, New Zealand: University of Otago. www.otago.ac.nz\/__data\/assets\/pdf_file\/0025\/327481\/nzdep2018-index-of-deprivation-research-report-interim-dec-2019-730394.pdf<\/ext-link><\/p>"},{"key":"key-10.48130\/pedi-0026-0003-39","doi-asserted-by":"publisher","unstructured":"

Nixon G, Whitehead J, Davie G, de Graaf B, Crengle S, et al. 2022. Defining rural in Aotearoa<\/i> New Zealand: a novel geographic classification for health purposes. New Zealand Medical Journal<\/ext-link><\/i> 135(1559):24\u221240<\/p>","DOI":"10.26635\/6965.5495"},{"key":"key-10.48130\/pedi-0026-0003-40","doi-asserted-by":"publisher","unstructured":"

Mikkelsen KH, Knop FK, Vilsb\u00f8ll T, Frost M, Hallas J, et al. 2017. Use of antibiotics in childhood and risk of Type 1 diabetes: a population-based case\u2013control study. Diabetic Medicine<\/ext-link><\/i> 34(2):272\u2212277<\/p>","DOI":"10.1111\/dme.13262"},{"key":"key-10.48130\/pedi-0026-0003-41","doi-asserted-by":"publisher","unstructured":"

Beier MA, Setoguchi S, Gerhard T, Roy J, Koffman D, et al. 2025. Early childhood antibiotics and chronic pediatric conditions: a retrospective cohort study. The Journal of Infectious Diseases<\/ext-link><\/i> 232(3):659\u2212668<\/p>","DOI":"10.1093\/infdis\/jiaf191"},{"key":"key-10.48130\/pedi-0026-0003-42","doi-asserted-by":"publisher","unstructured":"

Brandt S, Thorsen J, Rasmussen MA, Chawes B, B\u00f8nnelykke K, et al. 2025. Use of antibiotics in early life and development of diseases in childhood: nationwide registry study. BMJ Medicine<\/ext-link><\/i> 4(1):e001064<\/p>","DOI":"10.1136\/bmjmed-2024-001064"},{"key":"key-10.48130\/pedi-0026-0003-43","doi-asserted-by":"publisher","unstructured":"

Patangia DV, Anthony Ryan C, Dempsey E, Paul Ross R, Stanton C. 2022. Impact of antibiotics on the human microbiome and consequences for host health. MicrobiologyOpen<\/ext-link><\/i> 11:e1260<\/p>","DOI":"10.1002\/mbo3.1260"},{"key":"key-10.48130\/pedi-0026-0003-44","doi-asserted-by":"publisher","unstructured":"

Schwartz DJ, Langdon AE, Dantas G. 2020. Understanding the impact of antibiotic perturbation on the human microbiome. Genome Medicine<\/ext-link><\/i> 12(1):82<\/p>","DOI":"10.1186\/s13073-020-00782-x"},{"key":"key-10.48130\/pedi-0026-0003-45","doi-asserted-by":"publisher","unstructured":"

Tern\u00e1k G, Ber\u00e9nyi K, Kun S, Szigeti N, Decsi T, et al. 2021. Inverse association between use of broad spectrum penicllin with beta-lactamase inhibitors and prevalence of type 1 diabetes mellitus in Europe. Scientific Reports<\/ext-link><\/i> 11:16768<\/p>","DOI":"10.1038\/s41598-021-96301-y"},{"key":"key-10.48130\/pedi-0026-0003-46","doi-asserted-by":"publisher","unstructured":"

Lathakumari RH, Vajravelu LK, Satheesan A, Ravi S, Thulukanam J. 2024. Antibiotics and the gut microbiome: Understanding the impact on human health. Medicine in Microecology<\/ext-link><\/i> 20:100106<\/p>","DOI":"10.1016\/j.medmic.2024.100106"},{"key":"key-10.48130\/pedi-0026-0003-47","doi-asserted-by":"publisher","unstructured":"

Vangay P, Ward T, Gerber JS, Knights D. 2015. Antibiotics, pediatric dysbiosis, and disease. Cell Host & Microbe<\/ext-link><\/i> 17(5):553\u2212564<\/p>","DOI":"10.1016\/j.chom.2015.04.006"},{"key":"key-10.48130\/pedi-0026-0003-48","doi-asserted-by":"publisher","unstructured":"

Zawada A, Skrzypczak-Zieli\u0144ska M, Gondek S, Witkowski P, Rychter AM, et al. 2024. The role of genetic risk factors, diet, and gut microbiota in type 1 diabetes mellitus, pancreas and pancreatic islet transplantation. Endokrynologia Polska<\/ext-link><\/i> 75:140-147<\/p>","DOI":"10.5603\/ep.98903"},{"key":"key-10.48130\/pedi-0026-0003-49","doi-asserted-by":"publisher","unstructured":"

Lin HC, Wang CH, Tsai FJ, Hwang KP, Chen W, et al. 2015. Enterovirus infection is associated with an increased risk of childhood type 1 diabetes in Taiwan: a nationwide population-based cohort study. Diabetologia<\/ext-link><\/i> 58(1):79\u221286<\/p>","DOI":"10.1007\/s00125-014-3400-z"},{"key":"key-10.48130\/pedi-0026-0003-50","doi-asserted-by":"publisher","unstructured":"

Goff DA, Kullar R, Goldstein EJC, Gilchrist M, Nathwani D, et al. 2017. A global call from five countries to collaborate in antibiotic stewardship: united we succeed, divided we might fail. The Lancet Infectious Diseases<\/ext-link><\/i> 17(2):e56\u2212e63<\/p>","DOI":"10.1016\/S1473-3099(16)30386-3"}],"container-title":["Pediatric Diabetes"],"original-title":[],"deposited":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T01:40:21Z","timestamp":1782351621000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.maxapress.com\/article\/doi\/10.48130\/pedi-0026-0003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.48130\/pedi-0026-0003","relation":{},"ISSN":["1399-5448"],"issn-type":[{"value":"1399-5448","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]}}}